TELA Bio, Inc. (NASDAQ:TELA – Get Rating) – Analysts at Jefferies Financial Group issued their Q4 2023 EPS estimates for shares of TELA Bio in a report issued on Tuesday, March 21st. Jefferies Financial Group analyst M. Sarcone anticipates that the company will post earnings of ($0.50) per share for the quarter. The consensus estimate […]